ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 201–300 of 1,001
CTLA-4 and its role in autoimmune thyroid disease
Chistiakov, D., & Turakulov, R. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310021 · Cited by 154
Novel targets for immune-checkpoint inhibition in cancer
Borgeaud, M., Sandoval, J. L., Obéid, M., Banna, G. L., Michielin, O. A., Addeo, A., & Friedlaender, A. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102614 · Cited by 159
Co-Stimulatory Receptor Signaling in CAR-T Cells
Honikel, M. M., & Olejniczak, S. H. (2022) · Biomolecules · doi:10.3390/biom12091303 · Cited by 163
CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft Rejection
Jones, N. D., van Maurik, A., Hara, M., Spriewald, B. M., Witzke, O., Morris, P. J., & Wood, K. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1111 · Cited by 158
B7DC/PDL2 Promotes Tumor Immunity by a PD-1–independent Mechanism
Liu, X., Gao, J. X., Wen, J., Yin, L., Li, O., Zuo, T., Gajewski, T. F., Fu, Y.-X., Zheng, P., & Liu, Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022089 · Cited by 147
B7RP-1 Blockade Ameliorates Autoimmunity through Regulation of Follicular Helper T Cells
Hu, Y.-L., Metz, D. P., Chung, J., Siu, G., & Zhang, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1421 · Cited by 142
Bentebibel, S.-E., Schmitt, N., Banchereau, J., & Ueno, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100898108 · Cited by 145
The Cluster of BTN Genes in the Extended Major Histocompatibility Complex
Rhodes, D. A., Stammers, M., Malcherek, G., Beck, S., & Trowsdale, J. (2001) · Genomics · doi:10.1006/geno.2000.6406 · Cited by 146
Transcriptional Regulation of Th2 Differentiation by Inducible Costimulator
Nurieva, R., Duong, J., Kishikawa, H., Dianzani, U., Rojo, J. M., Ho, I., Flavell, R. A., & Dong, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00144-4 · Cited by 162
Wu, H. Y., Quintana, F. J., & Weiner, H. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6038 · Cited by 149
The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity
Harada, H., Salama, A. D., Sho, M., Izawa, A., Sandner, S. E., Ito, T., Akiba, H., Yagita∥, H., Sharpe, A. H., Freeman, G. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17008 · Cited by 146
Janssens, W., Carlier, V., Wu, B., VanderElst, L., Jacquemin, M. G., & Saint-Remy, J.-M. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4604 · Cited by 140
Cell fate decision: T-helper 1 and 2 subsets in immune responses.
Dong, C., & Flavell, R. A. (2000) · Arthritis Research · doi:10.1186/ar85 · Cited by 154
Constitutive and Inducible Expression of B7 Family of Ligands by Human Airway Epithelial Cells
Kim, J., Myers, A. C., Chen, L., Pardoll, D. M., Truong-Tran, Q.-A., Lane, A. P., McDyer, J. F., Fortuno, L., & Schleimer, R. P. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0129oc · Cited by 138
Iwai, H., Kozono, Y., Hirose, S., Akiba, H., Yagita∥, H., Okumura, K., Kohsaka, H., Miyasaka, N., & Azuma, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4332 · Cited by 155
The B7/CD28 costimulatory family in autoimmunity
Keir, M. E., & Sharpe, A. H. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00242.x · Cited by 136
Nagase, H., Takeoka, T., Urakawa, S., Morimoto-Okazawa, A., Kawashima, A., Iwahori, K., Takiguchi, S., Nishikawa, H., Sato, E., Sakaguchi, S., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30475 · Cited by 143
Arnett, H. A., Escobar, S. S., Gonzalez-Suarez, E., Budelsky, A. L., Steffen, L. A., Boiani, N., Zhang, M., Siu, G., Brewer, A. W., & Viney, J. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1523 · Cited by 139
McHeyzer‐Williams, L. J., Driver, D. J., & McHeyzer‐Williams, M. G. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200101000-00010 · Cited by 166
Bessa, J., Köpf, M., & Bachmann, M. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903949 · Cited by 140
Emerging paradigms of T-cell co-stimulation
Kroczek, R. A., Mages, H. W., & Hutloff, A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.03.002 · Cited by 157
“These data demonstrate that ICOS cell surface expression on CD4þ T cells is, in spite of a consistent association with IL-10 under many circumstances [22,23,36 ,38–40], not hard-wired to certain cytokines.”
BackgroundSelf-citationDi Giacomo, A. M., Calabrò, L., Danielli, R., Fonsatti, E., Bertocci, E., Pesce, I., Fazio, C., Cutaia, O., Giannarelli, D., Miracco, C., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1418-6 · Cited by 135
CD28 Function: A Balance of Costimulatory and Regulatory Signals
Bour-Jordan, H., & Bluestone, J. A. (2002) · Journal of Clinical Immunology · doi:10.1023/a:1014256417651 · Cited by 176
Yoshinaga, S. K., Zhang, M., Pistillo, J., Horan, T., Khare, S. D., Miner, K. T., Sonnenberg, M. G., Boone, T., Brankow, D. W., Dai, T., et al. (2000) · International Immunology · doi:10.1093/intimm/12.10.1439 · Cited by 135
Soluble CD86 Is a Costimulatory Molecule for Human T Lymphocytes
Jeannin, P., Magistrelli, G., Aubry, J., Caron, G., Gauchat, J., Renno, T., Herbault, N., Goetsch, L., Blaecke, A., Dietrich, P., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00030-3 · Cited by 134
ICOS Ligation Recruits the p50α PI3K Regulatory Subunit to the Immunological Synapse
Fos, C., Salles, A., Lang, V., Carrette, F., Audebert, S., Pastor, S., Ghiotto, M., Olive, D., Bismuth, G., & Nunès, J. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1969 · Cited by 127
“T he T lymphocyte activation is based on multiple and com-plex interactions between T cells and APCs.”
BackgroundInfluentialMouse B7-H3 induces antitumor immunity
Sun, X., Vale, M., Leung, E. Y., Kanwar, J. R., Gupta, R., & Krissansen, G. W. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302070 · Cited by 137
Structural mechanisms of costimulation
Schwartz, J.-C. D., Zhang, X., Nathenson, S. G., & Almo, S. C. (2002) · Nature Immunology · doi:10.1038/ni0502-427 · Cited by 146
ICOS Costimulation Requires IL-2 and Can Be Prevented by CTLA-4 Engagement
Riley, J. L., Blair, P. J., Musser, J. T., Abe, R., Tezuka, K., Tsuji, T., & June, C. H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4943 · Cited by 130
Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles
Zhang, M., Kim, J. A., & Huang, A. Y.-C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00341 · Cited by 133
Altered T cell signalling in ageing
Pawelec, G., Hirokawa, K., & Fülöp, T. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00290-1 · Cited by 134
“Moreover, in addition to the CD28/CD152 receptors with CD80/CD86 ligands, there is a third CD28-family member designated ICOS (for inducible costimulator), expressed on activated T cells which, when ligated, results in costimulation producing little IL 2 but large amounts IL 10 (Hutloff et al., 1999).”
BackgroundUnderstanding the development and function of T follicular helper cells
Nurieva, R., & Chung, Y. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.24 · Cited by 161
Tesciuba, A. G., Subudhi, S., Rother, R. P., Faas, S. J., Frantz, A. M., Elliot, D., Weinstock, J., Matis, L. A., Bluestone, J. A., & Sperling, A. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1996 · Cited by 129
Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
Cinier, J., Hubert, M., Besson, L., Roio, A. D., Rodriguez, C., Lombardi, V., Caux, C., & Ménétrier‐Caux, C. (2021) · Cancers · doi:10.3390/cancers13081850 · Cited by 136
“However, as ICOS could be overexpressed on activated effector T cells after Ag recognition [366] or anti-CTLA-4 immunotherapy [367–369], the windows of treatment need to be restricted to the period of time when only Tregs express high ICOS levels.”
BackgroundMemory T cells need CD28 costimulation to remember
Boesteanu, A. C., & Katsikis, P. D. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.02.005 · Cited by 127
Abnormalities of B cell subsets in patients with systemic lupus erythematosus
Dörner, T., Jacobi, A. M., Lee, J., & Lipsky, P. E. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.06.009 · Cited by 143
Human Circulating T Follicular Helper Cell Subsets in Health and Disease
Ueno, H. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0268-3 · Cited by 133
Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy
Amatore, F., Gorvel, L., & Olive, D. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1693540 · Cited by 130
Marafioti, T., Paterson, J. C., Ballabio, E., Chott, A., Natkunam, Y., Rodriguez‐Justo, M., Plonquet, A., Rodríguez-Pinilla, S. M., Klapper, W., Hansmann, M. L., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.010991 · Cited by 128
“The members of each family have been described to have structural and functional similarities, but also unique features.(12,34) Some of these molecules are constitutively expressed (e.”
BackgroundVas, J., & Monestier, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.022 · Cited by 138
The nature of activatory and tolerogenic dendritic cell-derived signal II
Bakdash, G., Sittig, S. P., van Dijk, T., Figdor, C. G., & de Vries, I. J. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00053 · Cited by 135
Taylor, P. A., Panoskaltsis‐Mortari, A., Freeman, G. J., Sharpe, A. H., Noelle, R. J., Rudensky, A. Y., Mak, T. W., Serody, J. S., & Blazar, B. R. (2004) · Blood · doi:10.1182/blood-2004-10-3869 · Cited by 126
Nakayamada, S., Poholek, A. C., Lu, K. T., Takahashi, H., Kato, M., Iwata, S., Hirahara, K., Cannons, J. L., Schwartzberg, P. L., Vahedi, G., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300675 · Cited by 120
Witsch, E., Peiser, M., Hutloff, A., Büchner, K., Dorner, B. G., Jonuleit, H., Mages, H. W., & Kroczek, R. A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200209)32:9<2680::aid-immu2680>3.0.co;2-6 · Cited by 142
Self-citationFrontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells
Compte, E., Pontarotti, P., Collette, Y., Lopez, M., & Olive, D. (2004) · European Journal of Immunology · doi:10.1002/eji.200425227 · Cited by 132
Tamura, H., Dan, K., Tamada, K., Nakamura, K., Shioi, Y., Hyodo, H., Wang, S.-D., Dong, H., Chen, L., & Ogata, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2672 · Cited by 133
Iwai, H., Abe, M., Hirose, S., Tsushima, F., Tezuka, K., Akiba, H., Yagita∥, H., Okumura, K., Kohsaka, H., Miyasaka, N., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.2848 · Cited by 122
Activated Self-MHC-Reactive T Cells Have the Cytokine Phenotype of Th3/T Regulatory Cell 1 T Cells
Kitani, A., Chua, K., Nakamura, K., & Strober, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.691 · Cited by 121
Kallinich, T., Muche, J. M., Qin, S., Sterry, W., Audring, H., & Kroczek, R. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12555.x · Cited by 133
“Smith et al , 1986 ), F44 (inducible costimulator (ICOS), IgG1)”
Self-citationNanki, T., Takada, K., Komano, Y., Morio, T., Kanegane, H., Nakajima, A., Lipsky, P. E., & Miyasaka, N. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2823 · Cited by 121
Wiendl, H., Mitsdoerffer, M., Schneider, D., Melms, A., Lochmuller, H., Hohlfeld, R., & Weller, M. (2003) · Brain · doi:10.1093/brain/awg114 · Cited by 119
Fehlings, M., Simoni, Y., Penny, H. L., Becht, E., Loh, C. Y., Gubin, M. M., Ward, J. P., Wong, S. C., Schreiber, R. D., & Newell, E. W. (2017) · Nature Communications · doi:10.1038/s41467-017-00627-z · Cited by 115
ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
Xiao, Z., Mayer, A. T., Nobashi, T. W., & Gambhir, S. S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3265 · Cited by 121
Wang, S., & Chen, L. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.03.007 · Cited by 133
Stimulation Through Intercellular Adhesion Molecule-1 Provides a Second Signal for T Cell Activation
Chirathaworn, C., Kohlmeier, J. E., Tibbetts, S. A., Rumsey, L. M., Chan, M. A., & Benedict, S. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5530 · Cited by 117
Liu, X., Bai, X.-F., Wen, J., Gao, J.-X., Liu, J., Lu, P., Wang, Y., Zheng, P., & Liu, Y. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1339 · Cited by 119
de Vries, N. L., van Unen, V., Ijsselsteijn, M. E., Abdelaal, T., van der Breggen, R., Farina Sarasqueta, A., Mahfouz, A., Peeters, K. C. M. J., Höllt, T., Lelieveldt, B. P. F., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318672 · Cited by 121
Frederiksen, K. S., Lundsgaard, D., Freeman, J. A., Hughes, S. D., Holm, T. L., Skrumsager, B. K., Petri, A., Hansen, L. T., McArthur, G. A., Davis, I. D., et al. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0479-4 · Cited by 116
“The increased expression of inducible co-stimulator (ICOS), C1q binding protein, and CD26 in CD8 cells has previously been observed in T cell activation [5, 18, 44].”
BackgroundInducible costimulator is essential for collagen-induced arthritis
Nurieva, R. I., Treuting, P., Duong, J., Flavell, R. A., & Dong, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17321 · Cited by 117
RetractedCXCR5+ T cells: follicular homing takes center stage in T-helper-cell responses
Moser, B., Schaerli, P., & Loetscher, P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02218-4 · Cited by 123
Zygmunt, B. M., & Veldhoen, M. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387664-5.00005-4 · Cited by 146
T follicular helper cells in human autoimmunity
Ueno, H. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.08.003 · Cited by 125
T follicular helper–like cells contribute to skin fibrosis
Taylor, D. K., Mittereder, N., Kuta, E. G., Delaney, T. A., Burwell, T. J., Dacosta, K., Zhao, W., Cheng, L., Brown, C., Boutrin, A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5307 · Cited by 123
“2 of 15 Unlike CD28, which is constitutively expressed on T cells, ICOS is rapidly up-regulated on activated CD4+ effector T cells, and its expression is highest on T follicular helper (TFH) cells, thus positioning it as a pivotal regulator of humoral responses (19).”
BackgroundClinical Insights Into Novel Immune Checkpoint Inhibitors
Lee, J. B., Ha, S.-J., & Kim, H. R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681320 · Cited by 112
Peng, C., Huggins, M. A., Wanhainen, K. M., Knutson, T. P., Lu, H., Georgiev, H., Mittelsteadt, K. L., Jarjour, N. N., Wang, H., Hogquist, K. A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.017 · Cited by 119
Pedroza‐González, A., Zhou, G., Vargas-Méndez, E., Boor, P. P. C., Mancham, S., Verhoef, C. K., Polak, W. G., Grünhagen, D. J., Pan, Q., Janssen, H. L. A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008355 · Cited by 114
Immunotherapy in the treatment of non-small cell lung cancer
Sundar, R., Soong, R., Cho, B. C., Brahmer, J. R., & Soo, R. A. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.05.005 · Cited by 123
Two waves of memory B-cell generation in the primary immune response
Inamine, A., Takahashi, Y., Baba, N., Miyake, K., Tokuhisa, T., Takemori, T., & Abe, R. (2005) · International Immunology · doi:10.1093/intimm/dxh241 · Cited by 109
Syndecan-4 Mediates the Coinhibitory Function of DC-HIL on T Cell Activation
Chung, J.-S., Dougherty, I., Cruz, P. D., & Ariizumi, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5778 · Cited by 114
CD28-independent Costimulation of T Cells in Alloimmune Responses
Yamada, A., Kishimoto, K., Dong, V. M., Sho, M., Salama, A. D., Anosova, N. G., Bénichou, G., Mandelbrot, D. A., Sharpe, A. H., Turka, L. A., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.140 · Cited by 121
Meyran, D., Zhu, J. J., Butler, J., Tantalo, D. G. M., Macdonald, S., Nguyen, T. N., Wang, M., Thio, N., D’Souza, C., Qin, V. M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abk1900 · Cited by 121
“Furthermore, g_CD8 CAR-T cells expressedmore Ki67 and ICOS, indicating increased CD8 T cell activation and proliferation associated with CD4 T cell interactions (37, 38).”
BackgroundDeleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function
Malaspina, A., Moir, S. L., Kottilil, S., Hallahan, C. W., Ehler, L. A., Liu, S., Planta, M. A., Chun, T., & Fauci, A. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.5965 · Cited by 124
Perrin, P. J., June, C. H., Maldonado, J. H., Ratts, R. B., & Racke, M. K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1704 · Cited by 116
The right place at the right time: novel B7 family members regulate effector T cell responses
Liang, L., & Sha, W. C. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00342-4 · Cited by 127
Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
Liu, Y., Bewersdorf, J. P., Stahl, M. F., & Zeidan, A. M. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.12.001 · Cited by 116
Modulation of T-cell responses to alloantigens by TR6/DcR3
Zhang, J., Salcedo, T. W., Wan, X., Ullrich, S. J., Hu, B., Gregorio, T., Feng, P., Qi, S., Chen, H., Cho, Y. H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12159 · Cited by 111
“For example, signals through inducible costimulator (ICOS) have effects on activated T cells only, and this pathway enhances IL-10 but not IL-2 production (24); costimulation via signaling lymphocyte activation molecule (SLAM/CD150) enhances IFN-γ production and directs memory T cells toward Th0/Th1 responses (25); cr…”
BackgroundB7h is required for T cell activation, differentiation, and effector function
Nurieva, R. I., Mai, X. M., Forbush, K., Bevan, M. J., & Dong, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2335041100 · Cited by 111
LICOS, a primordial costimulatory ligand?
Brodie, D. W., Collins, A. V., Iaboni, A., Fennelly, J. A., Sparks, L. M., Xu, X.-N., van der Merwe, P. A., & Davis, S. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00383-3 · Cited by 111
“ICOS also differs from CD28 in that, when crosslinked with antibodies, it induces the production of the anti-inflammatory cytokine interleukin 10 (IL-10), rather than upregulating the synthesis of IL-2 [1].”
InfluentialNew directions in the basic and translational biology of interleukin-27
Wojno, E. D. T., & Hunter, C. A. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.11.003 · Cited by 112
Delays and Diversions Mark the Development of B Cell Responses to Borrelia burgdorferi Infection
Hastey, C. J., Elsner, R. A., Barthold, S. W., & Baumgarth, N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103735 · Cited by 114
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
Lühder, F., Chambers, C., Allison, J. P., Benoist, C., & Mathis, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200348397 · Cited by 101
Co-stimulatory and co-inhibitory pathways in cancer immunotherapy
O’Neill, R., & Cao, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.003 · Cited by 110
“Phosphorylation of PD1’s immunoreceptor tyrosine-based switch motif (ITSM) results in the direct dephosphorylation of signaling molecules directly downstream of the TCR. Ligation of PD1 augments PTEN inhibition of PI3K activity to decrease T cell proliferation, survival, protein synthesis, and IL-2 release [86].”
BackgroundInfluentialBromelain Modulates T Cell and B Cell Immune Responses in Vitro and in Vivo
Engwerda, C. R., Andrew, D., Ladhams, A., & Mynott, T. L. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1807 · Cited by 116
The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency
Yong, P. F. K., Salzer, U., & Grimbacher, B. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00764.x · Cited by 117
Schmidt, J., Rakočević, G., Raju, R. P., & Dalakas, M. C. (2004) · Brain · doi:10.1093/brain/awh148 · Cited by 104
“It interacts with its receptor ICOS (Hutloff et al., 1999) on T cells and can promote Th1 and Th2 responses (Carreno and Collins, 2002; Sharpe and Freeman, 2002).”
BackgroundLuo, C., Li, Y., Liu, W., Feng, H., Wang, H., Huang, X., Li, Q., & Ouyang, J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.12.001 · Cited by 111
“ICOS is important for CD4+ T cells to promote B cells in mice (Hutloff et al., 1999; McAdam et al., 2001; Tafuri et al., 2001).”
BackgroundNK cell triggering by the human costimulatory molecules CD80 and CD86.
Wilson, J. L., Charo, J., Martín-Fontecha, A., Dellabona, P., Casorati, G., Chambers, B., Kiessling, R., Bejarano, M., & Ljunggren, H. (1999) · Journal of Immunology · doi:10.4049/jimmunol.163.8.4207 · Cited by 118
The clinical impact of ICOS signal in colorectal cancer patients
Zhang, Y., Luo, Y., Qin, S., Mu, Y., Yang, Q., Yu, M., & Zhong, M. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1141857 · Cited by 110
Fcγ receptors and immunomodulatory antibodies in cancer
Gálvez‐Cancino, F., Simpson, A. P., Costoya, C., Matos, I. G., Qian, D., Peggs, K. S., Litchfield, K., & Quezada, S. A. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00637-8 · Cited by 104
“Structurally and functionally related to CD28, ICOS is a co-stimulatory receptor whose expression is induced on T cells following their activation 186 (Fig.”
On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis
Fountoulakis, S., & Tsatsoulis, A. A. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2004.01978.x · Cited by 117
Harada, Y., Ohgai, D., Watanabe, R., Okano, K., Koiwai, O., Tanabe, K., Toma, H., Altman, A., & Abe, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021305 · Cited by 97
Tuettenberg, A., Huter, E. N., Hubo, M., Horn, J., Knop, J., Grimbacher, B., Kroczek, R. A., Stoll, S., & Jonuleit, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802733 · Cited by 101
Self-citationAlissafi, T., Hatzioannou, A., Legaki, A. I., Varveri, A., & Verginis, P. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102310 · Cited by 106
Critical Role of OX40 in CD28 and CD154-Independent Rejection
Demirci, G., Amanullah, F., Kewalaramani, R., Yagita∥, H., Strom, T. B., Sayegh, M. H., & Li, X. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1691 · Cited by 100
Regulatory T cells and type 2 innate lymphoid cell‐dependent asthma
Aron, J., & Akbari, O. (2017) · Allergy · doi:10.1111/all.13139 · Cited by 104
Tuberculosis in Africa: Learning from Pathogenesis for Biomarker Identification
Kaufmann, S. H. E., & Parida, S. K. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.08.002 · Cited by 116
Wang, Y., Lupiani, B., Reddy, S. M., Lamont, S. J., & Zhou, H. (2014) · Poultry Science · doi:10.3382/ps.2013-03557 · Cited by 99
Pletinckx, K., Döhler, A., Pavlović, V., & Lutz, M. B. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00039 · Cited by 114
Regulation of immune and autoimmune responses by ICOS
Dong, C., & Nurieva, R. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00119-7 · Cited by 108
The Crohn's Disease-Associated Bacterial Protein I2 Is a Novel Enteric T Cell Superantigen
Dalwadi, H., Wei, B., Kronenberg, M., Sutton, C. L., & Braun, J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00164-9 · Cited by 98
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.